These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17891188)

  • 1. The Uhthoff phenomenon: a potential post transplant complication in advanced progressive multiple sclerosis.
    Morris ES; Sharrack B; Dalley CD; Snowden JA
    Bone Marrow Transplant; 2007 Nov; 40(10):1003-4. PubMed ID: 17891188
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation in multiple sclerosis.
    Rogojan C; Frederiksen JL
    Acta Neurol Scand; 2009 Dec; 120(6):371-82. PubMed ID: 19785643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic renal failure after hematopoietic stem cell transplantation].
    Boscutti G; Pizzolitto S; Patriarca F; De Maglio G; Bosco M; Boer E
    G Ital Nefrol; 2008; 25(4):459-74. PubMed ID: 18663693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal neurogenic pulmonary edema in a patient with progressive multiple sclerosis.
    Bramow S; Faber-Rod JC; Jacobsen C; Kutzelnigg A; Patrikios P; Sorensen PS; Lassmann H; Laursen H
    Mult Scler; 2008 Jun; 14(5):711-5. PubMed ID: 18566036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
    Denney DR; Lynch SG; Parmenter BA
    J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensory impairments in quiet standing in subjects with multiple sclerosis.
    Cattaneo D; Jonsdottir J
    Mult Scler; 2009 Jan; 15(1):59-67. PubMed ID: 18845654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is progressive multiple sclerosis a gray matter disease?
    Geurts JJ
    Ann Neurol; 2008 Sep; 64(3):230-2. PubMed ID: 18825672
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.
    Conte A; Bettolo CM; Onesti E; Frasca V; Iacovelli E; Gilio F; Giacomelli E; Gabriele M; Aragona M; Tomassini V; Pantano P; Pozzilli C; Inghilleri M
    Eur J Pain; 2009 May; 13(5):472-7. PubMed ID: 18603457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the natural history of MS: the need for complete data and rigorous definitions.
    Tremlett H; Zhao Y; Devonshire V
    Mult Scler; 2008 Sep; 14(8):1142-3; author reply 1144-7. PubMed ID: 18701573
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron overload in hematopoietic cell transplantation.
    Majhail NS; Lazarus HM; Burns LJ
    Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis.
    Liang J; Zhang H; Hua B; Wang H; Wang J; Han Z; Sun L
    Mult Scler; 2009 May; 15(5):644-6. PubMed ID: 19389752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychology of primary progressive multiple sclerosis].
    Paes RA; Alvarenga RM; Vasconcelos CC; Negreiros MA; Landeira-Fernández J
    Rev Neurol; 2009 Oct 1-15; 49(7):343-8. PubMed ID: 19774527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spongiform encephalopathy following allogeneic cord blood transplant.
    O'Brien D; Klopfenstein K; Gross TG; Baker P; Termuhlen A
    Pediatr Transplant; 2008 Feb; 12(1):95-8. PubMed ID: 18186895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope.
    Hartung HP; Aktas O
    Ann Neurol; 2009 Oct; 66(4):429-32. PubMed ID: 19847907
    [No Abstract]   [Full Text] [Related]  

  • 16. Dystonia and multiple sclerosis.
    Anlar B
    Brain Dev; 2005 Dec; 27(8):602; author reply 602. PubMed ID: 16310595
    [No Abstract]   [Full Text] [Related]  

  • 17. Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.
    Ukkonen M; Vahvelainen T; Hämäläinen P; Dastidar P; Elovaara I
    Mult Scler; 2009 Sep; 15(9):1055-61. PubMed ID: 19556313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
    Wirk B; Klumpp TR; Ulicny J; Herman JH; Gajewski JL; Martin ME; Emmons RV; Mangan KF
    Transfusion; 2008 Jan; 48(1):163-8. PubMed ID: 17900280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline.
    Peres E; Khaled Y; Krijanovski OI; Mineishi S; Levine JE; Kaul DR; Riddell J
    Transpl Infect Dis; 2009 Feb; 11(1):57-63. PubMed ID: 18983415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation.
    Lu JQ; Storek J; Metz L; Yong VW; Stevens AM; Nash RA; Joseph JT
    Arch Neurol; 2009 Jan; 66(1):116-20. PubMed ID: 19139309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.